Article Details

Nilo Therapeutics launches with $101 million Series A - GlobeNewswire

Retrieved on: 2025-10-08 19:08:36

Tags for this article:

Click the tags to see associated articles and topics

Nilo Therapeutics launches with $101 million Series A - GlobeNewswire. View article details on hiswai:

Excerpt

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo